JCR Pharmaceuticals Co., Ltd. (TYO:4552)
Japan · Delayed Price · Currency is JPY 665.00
-6.00 (-0.89%)
Jul 22, 2025, 3:30 PM JST
JCR Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, JCR Pharmaceuticals had annual revenue of 33.07B JPY, down -22.86%. JCR Pharmaceuticals had revenue of 7.19B in the quarter ending March 31, 2025, a decrease of -21.42%.
Revenue
33.07B
Revenue Growth
-22.86%
P/S Ratio
2.45
Revenue / Employee
33.51M
Employees
987
Market Cap
81.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 33.07B | -9.80B | -22.86% |
| Mar 31, 2024 | 42.87B | 8.53B | 24.83% |
| Mar 31, 2023 | 34.34B | -16.74B | -32.77% |
| Mar 31, 2022 | 51.08B | 21.00B | 69.79% |
| Mar 31, 2021 | 30.09B | 5.30B | 21.40% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |